T1	PROC 46 60	Estudio piloto
#1	AnnotatorNotes T1	C0031928; Pilot Projects; Research Activity
T2	CHEM 92 102	etravirina
#2	AnnotatorNotes T2	C1456409; etravirine; Organic Chemical · Pharmacologic Substance
T3	CHEM 104 107	ETR
T4	CHEM 111 121	doravirina
T5	CHEM 123 126	DOR
T6	LIVB 131 138	adultos
#3	AnnotatorNotes T6	C0001675; Adult; Age Group
T7	Age 131 138	adultos
T8	DISO 139 159	infectados por VIH-1
T9	CHEM 205 208	ETR
T10	PROC 231 286	Estudio abierto, de un solo brazo, unicéntrico y piloto
T11	CHEM 318 328	etravirina
#4	AnnotatorNotes T11	C1456409; etravirine; Organic Chemical · Pharmacologic Substance
T12	CHEM 330 333	ETR
T13	CHEM 337 347	doravirina
T14	CHEM 349 352	DOR
T15	LIVB 357 364	adultos
#5	AnnotatorNotes T15	C0001675; Adult; Age Group
T16	Age 357 364	adultos
T17	DISO 365 385	infectados por VIH-1
T18	CHEM 431 434	ETR
T19	DISO 458 491	Virus de Inmunodeficiencia Humana
T20	DISO 493 496	VIH
#6	AnnotatorNotes T20	C0458074; Human immunodeficiency virus (HIV) status; Finding
T21	LIVB 526 533	Sujetos
#7	AnnotatorNotes T21	C0681850; Study Subject; Group
T22	DISO 534 557	infectados por el VIH-1
T23	Age 567 575	≥18 años
T24	LIVB 599 607	paciente
#8	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T25	PROC 626 640	régimen de TAR
T26	PROC 651 671	ARN plasmático VIH-1
T27	Duration 695 729	al menos las 24 semanas anteriores
T28	Date 734 745	Actualmente
T29	PROC 760 767	régimen
#9	AnnotatorNotes T29	C0012159; Diet therapy; Health Care Activity
T30	CHEM 781 784	ETR
T31	Neg_cue 786 789	sin
T32	Negated 790 797	cambios
T33	Duration 806 831	las 24 semanas anteriores
T34	PROC 841 849	genotipo
T35	CHEM 893 896	ADN
#10	AnnotatorNotes T35	C0012854; DNA; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T36	PROC 1008 1016	Genotipo
T37	CHEM 1057 1060	ADN
#11	AnnotatorNotes T37	C0012854; DNA; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T38	DISO 1093 1103	Mutaciones
T39	LIVB 1232 1241	lactantes
#12	AnnotatorNotes T39	C0021270; Infant; Age Group
T40	LIVB 1243 1250	mujeres
#13	AnnotatorNotes T40	C0043210; Woman; Population Group | C0242665; wife; Family Group
T41	PROC 1259 1277	prueba de embarazo
#14	AnnotatorNotes T41	C0032976; Pregnancy Tests; Diagnostic Procedure
T42	PROC 1307 1316	detección
#15	AnnotatorNotes T42	C1511790; Detection; Therapeutic or Preventive Procedure
T43	LIVB 1318 1334	mujeres fértiles
T44	PHYS 1366 1374	concebir
#16	AnnotatorNotes T44	C0009637; Conception; Organism Function
T45	Neg_cue 1377 1379	no
T46	PROC 1417 1440	métodos anticonceptivos
#17	AnnotatorNotes T46	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T47	Negated 1417 1440	métodos anticonceptivos
T48	Neg_cue 1528 1534	evitar
T49	PHYS 1538 1546	embarazo
#18	AnnotatorNotes T49	C0032961; Pregnancy; Organism Function
T50	Negated 1538 1546	embarazo
T51	Duration 1589 1598	4 semanas
T52	CHEM 1629 1640	medicamento
#19	AnnotatorNotes T52	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T53	LIVB 1664 1671	mujeres
#20	AnnotatorNotes T53	C0043210; Woman; Population Group | C0242665; wife; Family Group
T54	PROC 1731 1752	cirugía esterilizante
T55	Age 1760 1778	mayores de 50 años
T56	PHYS 1783 1792	amenorrea
T57	Duration 1812 1827	más de 12 meses
T58	PROC 1838 1845	ingreso
#21	AnnotatorNotes T58	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T59	DISO 1862 1883	Infección tuberculosa
#22	AnnotatorNotes T59	C0041296; Tuberculosis; Disease or Syndrome
T60	DISO 1906 1923	condición clínica
T61	PROC 1926 1933	terapia
#23	AnnotatorNotes T61	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T62	LIVB 1954 1966	investigador
#24	AnnotatorNotes T62	C0035173; Research Personnel; Professional or Occupational Group
T63	LIVB 1981 1990	individuo
#25	AnnotatorNotes T63	C0027361; Persons; Population Group
T64	Neg_cue 1991 1993	no
T65	Negated 1998 2022	adecuado para el estudio
T66	Neg_cue 2025 2027	no
T67	Negated 2034 2060	cumplir con los requisitos
T68	CHEM 637 640	TAR
T69	PROC 852 855	GRT
T70	PROC 1050 1053	GRT
T71	LIVB 1211 1230	Mujeres embarazadas
T72	DISO 1084 1091	DOR-DRM
#26	AnnotatorNotes T72	Doravirine (DOR) Drug-Resistance Mutation
T73	Observation 160 186	virológicamente suprimidos
T74	Observation 191 202	resistencia
T75	Observation 386 412	virológicamente suprimidos
T76	Observation 417 428	resistencia
T77	Observation 589 594	Deseo
T78	Result_or_Value 672 686	< 50 copias/ml
T79	CONC 790 797	cambios
T80	Quantifier_or_Qualifier 868 877	agrupado/
T81	Quantifier_or_Qualifier 1017 1025	agrupado
T82	Quantifier_or_Qualifier 1105 1108	106
T83	Quantifier_or_Qualifier 1112 1115	188
T84	Quantifier_or_Qualifier 1120 1123	230
T85	Result_or_Value 1278 1286	positiva
T86	Quantifier_or_Qualifier 1326 1334	fértiles
T87	Quantifier_or_Qualifier 1335 1354	sexualmente activas
T88	Observation 1359 1374	deseen concebir
T89	Observation 1386 1396	dispuestas
T90	Quantifier_or_Qualifier 1503 1522	altamente efectivos
T91	Quantifier_or_Qualifier 1793 1803	espontánea
T92	Quantifier_or_Qualifier 1884 1890	activa
T93	Observation 1998 2022	adecuado para el estudio
T94	Observation 2034 2076	cumplir con los requisitos de dosificación
T95	Patient 131 138	adultos
T96	Patient 357 364	adultos
T97	Patient 526 533	Sujetos
T98	Patient 599 607	paciente
T99	Patient 1211 1230	Mujeres embarazadas
T100	Patient 1232 1241	lactantes
T101	Patient 1243 1250	mujeres
T102	Patient 1318 1334	mujeres fértiles
T103	History_of 1731 1752	cirugía esterilizante
T104	Other 1954 1966	investigador
T105	Patient 1981 1990	individuo
